✦ LIBER ✦

A cost-effectiveness analysis of axillary node dissection in postmenopausal woman with estrogen receptor–positive breast cancer and clinically negative axillary nodes

✍ Scribed by Edward M. Copeland III

Book ID: 117221235
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 20 KB
Volume: 126
Category: Article
ISSN: 0039-6060
DOI: 10.1016/s0039-6060(99)70046-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A cost-effectiveness analysis of axillar

A cost-effectiveness analysis of axillary node dissection in postmenopausal women with estrogen receptor–positive breast cancer and clinically negative axillary nodes

✍ Richard K. Orr; Nananda F. Col; Karen M. Kuntz 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 51 KB

P64 A randomized trial of axillary disse

P64 A randomized trial of axillary dissection versus no axillary dissection for patients with clinically node negative breast cancer and micrometastases in the sentinel node

✍ V. Galimberti; R. Cecilio Sahium de Almeida; J. Rodriguez; G. Pagani; A. Sagona; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Impact of axillary lymph node dissection

Impact of axillary lymph node dissection on breast cancer outcome in clinically node negative patients : A Systematic Review and Meta-Analysis

✍ Mona Sanghani; Ethan M. Balk; Blake Cady 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 336 KB 👁 2 views

## Abstract ## BACKGROUND: The regional lymph node control and survival impact of axillary dissection in breast cancer has been the subject of multiple randomized trials, with various results. This study reviews and conducts a meta‐analysis of contemporary trials of axillary dissection in patients

Preliminary Outcome Analysis in Patients

Preliminary Outcome Analysis in Patients With Breast Cancer and a Positive Sentinel Lymph Node Who Declined Axillary Dissection

✍ Jerri S. Fant; Michael D. Grant; Sally M. Knox; Sheryl A. Livingston; Kimberly R 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 62 KB

Seven years of tamoxifen no better than

Seven years of tamoxifen no better than 5 years among women with estrogen receptor-positive breast cancer and negative axillary nodes

✍ Kaija Holli 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 76 KB

A 10-year follow-up of treatment outcome

A 10-year follow-up of treatment outcomes in patients with early stage breast cancer and clinically negative axillary nodes treated with tangential breast irradiation following sentinel lymph node dissection or axillary clearance

✍ A. Gabriella Wernicke; Robert L. Goodman; Bruce C. Turner; Lydia T. Komarnicky; 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 336 KB